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This study was designed to determine the effect of Calendula officinalis flowers extract mouthwash as oral gel on
radiation-induced oropharyngeal mucositis (OM) in patients with head-and-neck cancer. Forty patients with neck and
head cancers under radiotherapy or concurrent chemoradiotherapy protocols were randomly assigned to receive
either 2% calendula extract mouthwash or placebo (20 patients in each group). Patients were treated with telecobalt
radiotherapy at conventional fractionation (200 cGy/fraction, five fractions weekly, 30–35 fractions within 4–7 weeks).
The oropharyngeal mucositis was evaluated by two clinical investigators (a radiation oncologist and a dentist), using
the oral mucositis assessment scale (OMAS). Trying to find out the possible mechanism of action of the treatment, total
antioxidant, polyphenol and flavonoid contents, and quercetin concentration of the mouth wash were measured.
Calendula mouthwash significantly decreased the intensity of OM compared to placebo at week 2 (score: 5.5 vs. 6.8,
p = 0.019), week 3 (score: 8.25 vs. 10.95, p < 0.0001) and week 6 (score: 11.4 vs. 13.35, p = 0.031). Total antioxidant,
polyphenol and flavonoid contents and quercetin concentration of the 2% extract were 2353.4 ± 56.5 μM, 313.40 ±
6.52 mg/g, 76.66 ± 23.24 mg/g, and 19.41 ± 4.34 mg/l, respectively. Calendula extract gel could be effective on
decreasing the intensity of radiotherapy- induced OM during the treatment and antioxidant capacity may be partly
responsible for the effect.
Keywords: Radiotherapy-induced oral mucositis, OMAS (oral mucositis assessment scale), Calendula officinalis,
Antioxidant capacity, Gel formulationIntroduction
One of the most commonly perturbing adverse effect of
radiotherapy (RT) in head and neck cancers is oropharyn-
geal mucositis (OM) which comprises the main dose limit-
ing side effect [1]. The OM has been reported by patients
to be as the worst side effect of cancer radiotherapy [2,3].
Triottie et al. stated that the incidence of radiotherapy
induced OM in head and neck cancer patients is more
than 80% [3]. The OM, as a result of cancer management,* Correspondence: moslemi_d@yahoo.com
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reproduction in any medium, provided the oris defined as inflammation of oral mucosa, typically
manifesting as atrophy, swelling, erythema and ulceration
[4]. Up to this date, no approved standard intervention
has been found for the prevention or treatment of
radiotherapy-induced OM. Several strategies are being ac-
tively investigated, which are based on the mechanistic
interruption of one or more pathobiological pathways in-
volved in this condition [5]. A large number of treatments
and strategies have been studied for OM such as, growth
factors, cytokines, antibiotics, anti-inflammatory agents,
cryotherapy, mucosal protectors [6,7] and traditional ther-
apy such as pure honey [8] and herbal medicines [9]. As an
example, it has been shown that chamomile mouthwash, isLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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OM [9].
Calendula officinalis, commonly known as Marigold,
is used in the Western and Asian countries for its anti-
inflammatory properties [10]. According to some re-
ports, the extract of this plant possesses some pharma-
cological activities which include antioxidant action,
anti–inflammatory, antibacterial, antifungal, and antiviral
properties [11]. Results of one clinical trial showed that
calendula officinalis was highly effective in the preven-
tion of acute dermatitis in patients with cancer undergo-
ing postoperative irradiation [12]. It was observed that
this plant has cytotoxic effect on tumor cell lines in vitro
and anticancer activity in vivo [13]. According to the
mentioned properties for calendula officinalis such as
anti-inflammatory, anti bacterial, and antioxidant effects
and considering the pathobiology of OM, it would be in-
teresting to evaluate its effect on radiation-induced OM.
Based on these concepts; this study was designed to de-
termine the effect of calendula flowers extract mouth-
wash as gel formulation in the OM of head and neck
cancers radiotherapy.Methods
Patient selection
In this study forty patients (20 males and 20 females) with
a diagnosis of head and neck cancers from Shahid-Rajaie
radiotherapy center (Babolsar city, Northern Iran) were
recruited. The patients with proven squamous cell cancers
of head and neck were randomly divided into two equal
groups either received calendula extract mouthwash or
placebo (control group). Patients receiving curative radio-
therapy or chemoradiotherapy were informed to take oral
mouth wash calendula 5 ml b.i.d (12 hours interval). In-
formed consents were taken from the patients and they
were instructed for oral hygiene care, avoiding spicy foods
and smoking.
Patients received radiotherapy or chemoradiotherapy
with a curative intent. In chemoradiotherapy groups, pa-
tients treated concurrent radiotherapy and chemotherapy,
receiving cisplatin (100 mg/m2) with or without 5-
fluroracil (5-FU) on the first 3 days of the first week then
repeated every 3 weeks during treatment period. They
were treated using cobalt-60 at 80 cm SSD. Two parallel-
opposed lateral fields and an anterior lower neck field
were used in daily treatment with a mid-plane radiation
dose of 200 cGy to a total of 6000 –7000 cGy in 30–35
treatment sessions. The spinal cord dose was restricted to
be <4600 cGy. A boost in dose of 1600–2400 cGy was
given to residual disease at the primary site. Shielding
blocks were used individually in cases of need. Planning
target volume received at least 6000 cGy total radiation
dose (200 cGy-5 days/week), with the entire of oropharynxand oral cavity at least 3 cm anterior to the retromolar tri-
gone (no less than one third of the oral cavity) in the pri-
mary beam and Karnofsky Performance Status (KPS) >70
were the inclusion criteria.
Exclusion criteria included: history of head and neck
radiotherapy, patient’s refusal, comorbid disease (dia-
betes mellitus, hypertension, collagen vascular disease,
systemic infection, cardiac disease, etc.), poor oral hy-
giene [infection (viral, bacterial or fungal), active gingi-
vitis or oral ulcer] and concurrent medications.Study design
This investigation was conducted as a placebo-controlled
clinical trial. The protocol was approved by Ethics Commit-
tee of Babol University of Medical Sciences, Babol, Iran and
it was registered in Iranian Registry of Clinical Trials (www.
irct.ir) with ID No: IRCT201106076734N1. The informed
consented patients were divided randomly into two groups
of either calendula or placebo (20 patients in calendula
group, and 20 patients in placebo group). To consider
probable gender effect,we allocated 10 men and 10 women
in both calendula and placebo groups. Also to ensure reli-
able outcomes, the patients’ tumor sites were matched by a
radiation oncologist. Radiotherapy was implemented during
30 to 35 sessions in 7 weeks period with an accumulative
dose of 6000 to 7000 cGy. From the beginning of radiother-
apy, patients were given either placebo or 2% calendula
extract mouthwash as a gel formulation. Drugs were ad-
ministered two times daily, each time 5 ml to be held for at
least one minute in oral cavity. This investigation was a
double blind study. Calendula and placebo mouthwashes
had a same taste, shape and odor. The OM severity in all
patients was measured using Oral Mucositis Assessment
Scale (OMAS) scores. It is a validated reliable semi quanti-
tative tissue injury scoring scale, with demonstrated intra
and inter-observer reproducibility [14]. This scoring system
was introduced by Sonis (15) as a simple method to accur-
ately evaluate the mucositis. Oral cavity is divided into 9 re-
gions: hard and soft palate, floor of mouth, upper and lower
lips, left and right buccal mucosa, left and right ventral and
lateral tongue. All regions of oral cavity had been assessed
for erythma and ulcer.
Erythema considered as: 0 point (no erythema), 1
point (mild to moderate erythema) and 2 points (severe
erythema). For ulcers as follows: 0 point (no ulcer), 1
point (ulcer <1 cm), 2 points (ulcer 1–3 cm) and 3
points (ulcer >3 cm).
Oropharyngeal mucositis was evaluated by two physicians
(a radiation oncologist and a dentist), using the OMAS.
Indices were taken weekly during the treatment period.
The maximum and minimum scores were 45 and 0, re-
spectively [15]. Considering the treatment period of 7 weeks,
6 indices were provided for each patient.
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Dry and pulverized calendula officinalis flowers were pro-
vided from local resources and it was identified and
authenticated by herbal section of Department of Pharma-
cology, Faculty of Medicine, Babol University of Medical
Science, Babol, Iran and a voucher specimen (No:
CS_00236) was deposited.
Extract of Calendula was made by maceration in etha-
nol 70% for a 72 hour period. In order to prepare the ve-
hicle of the mouthwash we used following ingredients:
Carboxymethyl cellulose (CMC) (15 g), glycerin (25 ml),
methyl paraben (1.5 g), prophylparaben (0.2 g), ethanol
95o (10 ml), and distilled water. The alcohol concentra-
tion in the final solution was one percent. The vehicle as
the base of mouthwash was prepared as follows: first
CMC was dissolved in about 250 ml distilled water, then
distilled water was added gradually till the primarily vol-
ume reached 800 ml, then methyl and prophylparaben
were dissolved in glycerin in a temperature of 70 to
100°C. Afterwards 100 ml of primary gel (CMC + DW)
was added to them, and then, 10 ml of ethanol in 95°
was added. The present solution was mixed to primary
gel and remaining distilled was added to this mixture till
to reach a maximum volume 1000 ml. After the prepar-
ation of mouthwash base, we added 20 g calendula ex-
tract for a total volume of 1000 ml, and mixed it till the
mixture became uniform, in order to provide 2% calen-
dula mouthwash. The placebo mouthwash is the mouth-
wash base which has been matched in odor, shape, and
taste to calendula mouthwash.HPLC
Quercetin (main flavonoid aglycon) standard was pur-
chased from Sigma Chemical Co. (St. Louis, MO,USA).
Standard stock solution of this aglycone (20 μml-1) was
prepared in methanol HPLC grade as a solvent and the
linearity of peaks area to concentration (r = 0.983) was cal-
culated using regression analysis. All solvents used for
chromatographic purposes were of HPLC grade. HPLC
was performed using a Knauer Smartline Liquid Chroma-
tography System (Knauer, Germany) that consisted of a
four-channel pump, UV/VIS detector and an injection
valve, to which a 20 μl sample loop was attached. Data ac-
quisition and processing were performed on a personal
computer using Chromgate software. Sample injections
were performed using a 100 μl syringe (Hamilton, Reno,
Nevada, USA). The column was a Prontosil #60-5, C18 H
column that was 4.6 mm in diameter and 250 mm in
length. A purification system (HastaranTeb Co, FNR12,
Tehran, Iran) was used for the filtration (deionization) of
water. Chromatographic analysis was carried out using a
single-column isocratic reverse-phase method. The mobile
phase consisted of a 40:60 mixture of methanol and watercontaining 0.5% orthophosphoric acid. A flow rate of
0.8 mL/min was used. The analytes were detected by UV
absorption at 290 nm. The standard curve of quercetin
was prepared using standard solutions of different concen-
trations (20, 10, 4, 2 and 1 μgml-1). The volume for each
injection was 20 μl.
Sample Preparation for HPLC analysis: The plant flowers
(100 mg) with 6 ml 25% hydrochloric acid and 94 ml
methanol was extracted and filtered through a 13 mm,
2-μm pore, using Whatman filter. The filtrate was finally di-
luted with methanol in the ratio 1:2 and 10 μl of this solu-
tion was injected for HPLC analysis. Each extract was
diluted and injected in five repeats.Determination of total antioxidant activity
Total antioxidant activity was estimated by a FRAP (ferric
reducing antioxidant power) assay [16]. Five different con-
centrations of the calendula extracts (0.1, 0.2, 0.4, 0.5, 1%)
were used for this test. Principle of this method is based
on the reduction of a ferric-tripyridyltriazine complex to
its ferrous, colored form in the presence of antioxidants
and the absorbance was read at 593 nm with a single
beam Jenway UV/Visible spectrophotometer (UK) and
compared to a blank. The final result was expressed as the
concentration of antioxidant with a ferric reducing ability
equivalent to that of 1 mmol/l FeSO4 [17].
Total phenols determination
Total phenolic contents were evaluated using Folin-
Ciocalteu reagent [18]. A dilute solution of the extract
(0.5 ml of 1:100 mgml-1 methanolic extract) or gallic
acid (phenolic standard compound) was mixed with the
reagent (5 ml, 1:10 diluted with distilled water) and
aqueous Na2CO3 (4 ml, 1 M). After 15 min standby
period, the total phenol contents were assayed using
colorimetry at 765 nm. The standard curve was obtained
using 0, 25, 50, 100, 150, 250 and 500 mg l-1 solutions
of gallic acid in methanol:water (50:50, v/v). Total
phenolic contents were shown as mg/g (of dry mass) of
gallic acid equivalent, which is a common reference
compound.
Total flavonoids determination
Total flavonoid contents were determined using aluminum
chloride colorimetric method [19]. Calendula methanolic
extract (0.5 ml of %1 extract) was mixed with 1.5 ml of
methanol, 0.1 ml of 10% aluminum chloride, 0.1 ml of
1 M potassium acetate and 2.8 ml of distilled water. Then
the mixture was left at room temperature for 30 min; the
absorbance of the reaction mixture was measured at
415 nm. Different quercetin solutions at concentrations
6.25, 12.5, 25, 50 and 100 mg l-1 in methanol were pre-
pared to obtaining standard curve.
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Data were analyzed by using t-test, Mann–Whitney
U test, one-way ANOVA and repeated measures
ANOVA tests. The p values of less than 0.05 were con-
sidered as the statistical significant difference.
Results
In the pcacebo group , six patients were excluded : Four
patients had left the study , two patients had severe
mucositis and treated with another drugs. In the calen-
dula group ,three patients were exclude that had left the
study. Statistical analysis was performed on 20 and18 pa-
tients in calendula and placebo groups respectively
(Additional file 1). Thirty eight patients with mean age
54.1 (range 46–72) completed the study. Individual char-
acteristics of the patients are detailed in Table 1. None
of the patients in calendula group underwent medica-
tion for OM severity and radiotherapy was not ceased
for this reason. In calendula group three patients did
not show OM in the whole treatment period. OM inten-
sity was measured according to OMAS scores at the end
of each week for both calendula and placebo groups.
OMAS scores were significantly lower in calendula group
compared to placebo at week 2, 3 and 6 of the study
(Figure 1). According to repeated measures ANOVA test,
the differences between OMAS of calendula and placebo
during the weeks of evaluation were statistical significant
(p < 0.001) and OM intensity was significantly decreased in
calendula compared to placebo group (p = 0.048). Al-
though OM intensity was higher in women, but in both
group of genders calendula had better results compared to
placebo (Figure 2). Quercetin concentration as a main fla-
vonoid content was measured. According to the standard
curve, the mean ± SD of quercetin concentration in theTable 1 Comparison of the patients’ individual results in
among two treatment groups
Treatment groups Placebo Calendula
extractParameters
Number of patients 20 20
Male 10 10
female 10 10
Mean age 52.8 52.2
Tumor location
Nasopharynx 10 11
Oral Cavity 7 6
Salivary glands 1 -
Tonsil 2 3
Radiotherapy alone 4 3
Chemoradiotherapy 16 17
Total 20 20extract was 19.41 ± 4.34 mg/l (%RSD = 15.33). HPLC fin-
gerprint of hydroalcolic extract of calendula officinalis is
shown in Figure 3. The flavonoid contents of calendula
flowers extract based on quercetin equivalent concentra-
tion (the standard curve equation: y =0.007× + 0.3337, r =
0.998) was 76.66 ± 23.24 mg/g.
The FRAP results for ferric reducing ability in five
concentrations (0.1, 0.2, 0.4, 0.5, and 1%) of calendula ex-
tracts were 565.5 ± 126.5, 1059.2 ± 305.1, 1714.3 ± 318.5,
1877.3 ± 381.8 and 2353.4 ± 56.5 μM, respectively. Total
phenol using gallic acid concentration (the standard curve
equation: y =0.005× + 0.001, r = 0.999) was 313.40 ±
6.52 mg/g of gallic acid equivalent in the extract of calen-
dula officinalis.
Discussion
When biological changes induced by radiotherapy is being
initiated, an extensive damage is seen to result in destruc-
tion of intact mucosa [20]. In the present study three pa-
tients of calendula group didn’t demonstrate OM after
radiotherapy in the whole treatment period.
Most interventions have been proven to be ineffective
and current clinical management of OM is mainly palliative
and focused on pain control [21]. Up to date, no study has
investigated the effect of calendula officinalis on radiation-
induced OM. Many beneficial activities reported for the
plant are mainly related to the contents of various second-
ary metabolites such as polyphenols, cartenoids, triterpenes
and essential oils [22]. Several calendula therapeutic prop-
erties such as, anti-inflammatory, anti-tumorogenic [23,24]
have been reported. In addition, in vitro anti-microbial ac-
tivities of its oils have been proven [25]. Regardless of bac-






















Figure 1 Mean (±SEM) of OMAS scores changes by time (week)
in placebo and calendula treatment group. * p = 0.019,
















Figure 2 Mean (±SEM) of OMAS scores changes by sex and
time (week) in placebo and calendula treatment group.
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ing ulceration needs to be re-established by normal bacter-
ial proportions for spontaneous ulcer resolution [26].
Antioxidant activity and wound healing properties of calen-
dula has been reported [27]. According to the present re-
sults, antioxidant activity of the extract was confirmed. It
has been demonstrated that plant polyphenols such as fla-
vonoids are a most important active natural products
possessing antioxidant activity. This effect is considerable
on human health. The flavonoids which contain hydroxyl
groups are responsible for the radical scavenging [28-30]
or chelating [31-33] effects. These agents accompanying
with several endogenous antioxidants may play an promin-
ent role in maximum protection against oxidative stressFigure 3 HPLC fingerprint obtained from hydroalcolic extract of calen
[Q, 20 microgram/ml] (B). Method characteristics: methanol (40%), 0.5% a
detection at 290 nm.induced by high level of reactive oxygen species (ROS) in
the body. On the other hand, phenolic compounds are a
class of antioxidant agents which act as free radical termi-
nators [34,35]. The ROS play a causative role in several
degenerative diseases, for example heart disease, athero-
sclerosis, hepatotoxicity, inflammation, tumor promotion,
and cancer [36-38]. In this study quercetin as a flavonoid
with anti-inflammatory effect [39-41] has been assayed in
the calendula flower extract and antioxidant capacity was
measured using FRAP test as well.
According to our investigation, the high contents of
the flovonoid and phenolic phytochemicals in calendula
officinalis and its antioxidant activity can support its high
radical scavenging activity and following protective effect
in radiotherapy- induced OM. Initiation phase of radio-
therapy or chemotherapy-induced injury is a critical first
step in the development of mucositis in which clonogenic
cell death and the production of ROS by injured cells are
the most dominant components. The initiation phase is a
rate-limiting step and by delaying or stopping it, it can be
prevented or minimized by regimen-related injury [42].
Considering the antioxidant properties of calendula, it may
act against ROS and prevents or delays the initiation phase.
In one study which evaluated laser activated calendula
extract (LACE), the LACE showed to be capable in vitro
inhibition of tumor cell proliferation, from 70 to 100%
when tested on a wide variety of human and murine tumor
cell lines. According to this study, LACE has immune-
modulatory activities [5,23,43]. There is very few safetydula officinalis flowers (A), compared to quercetin standard
queous solution of orthophosphpric acid (0.6%), flow rate, 0.8 ml/min,
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tration of calendula products should be avoided during
early stages of pregnancy due to its ability to stimulate
menstruation, also allergic hypersensitivity may cause a
problem for individuals sensitive to other members of the
plant family asteraceae [44]. It has been shown that calen-
dula extract toothpaste could effectively reduce plaque and
bleeding indexes in moderate to severe gingivitis. It has
been suggested that anti-inflammatory, antibacterial and
antioxidant properties of calendula may be responsible for
mentioned effects on gingivitis [45]. On the other hand, it
has been reported calendula flowers extract as an ointment
is effective in relieving pain of cracked or tender nipples
[46]. Duran et. al. (1996), showed positive preliminary
results for the administration of calendula ointment in the
treatment of venous leg ulcers [47]. It has been demon-
strated that calendula as a cream preparation protected
skin from irritant contact dermatitis caused by exposure to
sodium lauryl sulfate [48]. And as earlier mentioned,
calendula was highly effective in the prevention of acute
dermatitis in patients with cancer undergoing postopera-
tive irradiation [12]. Although, dermatitis and OM have
different pathobiology profiles, among reviewed clinical
trials the mentioned study was the closest one to our inves-
tigation. Generally there are few studies concerning effects
of herbal extracts on OM. The fact that calendula mouth-
wash could not completely prevent OM can be explained
by the complicated pathobiology of OM. It is also sug-
gested using calendula preparations in high dose of in
order to be more effective, and it perhaps need to be
applied for a longer duration of time, even though different
protocols for herbal extraction should be considered as a
factor when evaluating its effects. In the present study,
alcohol containing mouthwash was used. Although the
concentration of alcohol in final solution was lower than to
induce injury to the oral mucosa, the irritant effect of
alcohol may be questionable. In other words, it has been
found that chlorhexidine mouthwash containing alcohol,
can irritate the oral mucosa and it is effective in reducing
the duration of pain associated with oral mucositis induced
by chemotherapy (49). Regarding to comparison of OM in
two genders, it has been demonstrated that its intensity
is higher in females than males. Severe stomatitises
and radiotherapy induced OM, has been reported in
women [49]. This may be due to physiological differences
between two sexes but its exact mechanism remains to
be elucidated.
Finally, it is concluded that calendula officinalis is ef-
fective on decreasing OM intensity but cannot com-
pletely prevent its occurance. All patients could tolerate
it without any significant side effects (i.e., nausea and
vomiting). Furhter investigations are recommended to
elucidate the optimal dose and administration frequency
to have better outcomes in radiotherapy-induced OM.Additional file
Additional file 1: CONSORT 2010 flow diagram.
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